You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Olanzapine versus other atypical antipsychotics for schizophrenia
|
|---|---|
| Published in |
Cochrane database of systematic reviews, March 2010
|
| DOI | 10.1002/14651858.cd006654.pub2 |
| Pubmed ID | |
| Authors |
Katja Komossa, Christine Rummel‐Kluge, Heike Hunger, Franziska Schmid, Sandra Schwarz, Lorna Duggan, Werner Kissling, Stefan Leucht |
| Abstract |
In many countries of the industrialised world second generation ("atypical") antipsychotics have become the first line drug treatment for people with schizophrenia. The question as to whether, and if so how much, the effects of the various second generation antipsychotics differ is a matter of debate. In this review we examined how the efficacy and tolerability of olanzapine differs from that of other second generation antipsychotics. |
X Demographics
The data shown below were collected from the profiles of 15 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 3 | 20% |
| India | 2 | 13% |
| Ireland | 1 | 7% |
| Japan | 1 | 7% |
| Unknown | 8 | 53% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 9 | 60% |
| Practitioners (doctors, other healthcare professionals) | 4 | 27% |
| Scientists | 1 | 7% |
| Science communicators (journalists, bloggers, editors) | 1 | 7% |
Mendeley readers
The data shown below were compiled from readership statistics for 453 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 3 | <1% |
| Australia | 2 | <1% |
| Switzerland | 1 | <1% |
| Chile | 1 | <1% |
| Uruguay | 1 | <1% |
| Netherlands | 1 | <1% |
| Brazil | 1 | <1% |
| Sweden | 1 | <1% |
| South Africa | 1 | <1% |
| Other | 5 | 1% |
| Unknown | 436 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 72 | 16% |
| Researcher | 64 | 14% |
| Student > Bachelor | 51 | 11% |
| Student > Ph. D. Student | 40 | 9% |
| Other | 32 | 7% |
| Other | 92 | 20% |
| Unknown | 102 | 23% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 161 | 36% |
| Psychology | 48 | 11% |
| Agricultural and Biological Sciences | 26 | 6% |
| Nursing and Health Professions | 23 | 5% |
| Pharmacology, Toxicology and Pharmaceutical Science | 22 | 5% |
| Other | 55 | 12% |
| Unknown | 118 | 26% |
Attention Score in Context
This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 September 2022.
All research outputs
#2,766,526
of 25,457,297 outputs
Outputs from Cochrane database of systematic reviews
#5,379
of 11,499 outputs
Outputs of similar age
#10,985
of 110,348 outputs
Outputs of similar age from Cochrane database of systematic reviews
#16
of 71 outputs
Altmetric has tracked 25,457,297 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 11,499 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 40.0. This one has gotten more attention than average, scoring higher than 54% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 110,348 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 90% of its contemporaries.
We're also able to compare this research output to 71 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 77% of its contemporaries.